Literature DB >> 22494804

Pertussis control: time for something new?

Thomas A Clark1, Nancy E Messonnier, Stephen C Hadler.   

Abstract

Childhood acellular pertussis vaccines were licensed and implemented in the US in the 1990s following an effort to improve on the safety profile of whole-cell vaccines. However, waning of immunity from acellular vaccines may be driving the recent resurgence of pertussis, raising the need to consider new prevention strategies. Published by Elsevier Ltd.

Mesh：

Substances：

Year:  2012        PMID： 22494804     DOI： 10.1016/j.tim.2012.03.003

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


  28 in total

Review 1.  Prevention of pertussis: An unresolved problem.

Authors:  Susanna Esposito; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2018-07-24       Impact factor: 3.452

2.  Combating pertussis resurgence: One booster vaccination schedule does not fit all.

Authors:  Maria A Riolo; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

Review 3.  What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.

Authors:  Nicolas Burdin; Lori Kestenbaum Handy; Stanley A Plotkin
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-12-01       Impact factor: 10.005

4.  Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.

Authors:  L C Pawloski; A M Queenan; P K Cassiday; A S Lynch; M J Harrison; W Shang; M M Williams; K E Bowden; B Burgos-Rivera; X Qin; N Messonnier; M L Tondella
Journal:  Clin Vaccine Immunol       Date:  2013-11-20

Review 5.  Pertussis.

Authors:  Giovanni Gabutti; Chiara Azzari; Paolo Bonanni; Rosa Prato; Alberto E Tozzi; Alessandro Zanetti; Gianvincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 6.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

7.  The Bordetella pertussis type III secretion system tip complex protein Bsp22 is not a protective antigen and fails to elicit serum antibody responses during infection of humans and mice.

Authors:  Rodrigo Villarino Romero; Ilona Bibova; Ondrej Cerny; Branislav Vecerek; Tomas Wald; Oldrich Benada; Jana Zavadilova; Radim Osicka; Peter Sebo
Journal:  Infect Immun       Date:  2013-05-20       Impact factor: 3.441

8.  Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model.

Authors:  Jason M Warfel; Lindsey I Zimmerman; Tod J Merkel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

9.  Evaluation of Commercial Assays for Single-Point Diagnosis of Pertussis in the US.

Authors:  Lucia C Pawloski; Brian D Plikaytis; Monte D Martin; Stacey W Martin; Harry E Prince; Mary Lapé-Nixon; M Lucia Tondella
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164

Review 10.  Perplexities of pertussis: recent global epidemiological trends and their potential causes.

Authors:  D W Jackson; Pejman Rohani
Journal:  Epidemiol Infect       Date:  2013-01-16       Impact factor: 4.434
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.